Jenna Marie Cote, SLP - Speech-Language Pathologist in Amarillo, TX

Jenna Marie Cote, SLP is a Speech-language Pathologist based in Amarillo, Texas. Jenna Marie Cote is licensed to practice in Texas (license number 113601) and her current practice location is 5800 Bell St, Amarillo, Texas. She can be reached at her office (for appointments etc.) via phone at (806) 677-5224.

NPI number for Jenna Marie Cote is 1023500659 and her current mailing address is 5800 Bell St, Amarillo, Texas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1023500659.

Contact Information

Jenna Marie Cote, SLP
5800 Bell St,
Amarillo, TX 79109-6230
(806) 677-5224
(806) 677-5223



Healthcare Provider's Profile

Full NameJenna Marie Cote
GenderFemale
SpecialitySpeech-language Pathologist
Location5800 Bell St, Amarillo, Texas
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1023500659
  • Provider Enumeration Date: 05/30/2018
  • Last Update Date: 05/30/2018

Medical Identifiers

Medical identifiers for Jenna Marie Cote such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023500659NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 113601 (Texas)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jenna Marie Cote is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jenna Marie Cote, SLP
5800 Bell St,
Amarillo, TX 79109-6230

Ph: (806) 677-5224
Jenna Marie Cote, SLP
5800 Bell St,
Amarillo, TX 79109-6230

Ph: (806) 677-5224

News Archive

Striking increase in SARS-CoV-2 antibodies seen with prime dose AstraZeneca vaccine followed by Pfizer-BioNTech

Researchers in Germany have provided evidence that a booster shot of a messenger RNA (mRNA)-based coronavirus disease 2019 (COVID-19) vaccine following prime immunization with AstraZeneca's adenoviral vector-based vaccine is sufficient to achieve high levels of neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Cell powerhouses may be good therapeutic target for brain injury

Cell powerhouses are typically long and lean, but with brain injury such as stroke or trauma, they can quickly become bloated and dysfunctional, say scientists who documented the phenomena in real time for the first time in a living brain.

New device for busting nits

A team of biologists in the U.S. have come up with a device which eradicates head lice infestations in children.

AMC receives GWTG-Stroke Gold Performance Achievement Award for caring stroke patients

Adventist Medical Center recently received the American Heart Association/American Stroke Association's Get With The Guidelines (GWTG) - Stroke Gold Performance Achievement Award. The award recognizes AMC's commitment and success in implementing a higher standard of stroke care by ensuring that stroke patients receive treatment according to nationally accepted standards and recommendations provided by the AHA/ASA.

FDA announces science-based approach to protecting Americans from unsafe dietary supplements

Speaking before the American Society for Pharmacology and Experimental Therapeutics (ASPET) and the American Society for Nutritional Sciences, Dr. Lester M. Crawford, Acting Commissioner of the Food and Drug Administration (FDA), today outlined the agency's science-based approach to protecting American consumers from unsafe dietary supplements.

Read more News

› Verified 8 days ago


Speech-Language Pathologist in Amarillo, TX

Amber R Gollihugh,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 5507 Sw 9th Ave, Amarillo, TX 79106
Phone: 806-468-7611    
Sabrina Davis,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106
Phone: 806-355-9703    
Ms. Regina Robin Hurst, MS-CCC/SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1300 Wallace Blvd, Amarillo, TX 79106
Phone: 806-359-7681    
Melanie Beth Cummins, M.S. CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 5800 Bell St, Amarillo, TX 79109
Phone: 806-677-5000    Fax: 806-677-5225
Maribel Salas,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1901 Medi Park Dr # 32048, Amarillo, TX 79106
Phone: 806-253-2101    
Kimberly Bach,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 400 W 14th Ave # 79101, Amarillo, TX 79101
Phone: 806-337-5016    Fax: 806-337-5016

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.